Back to mobile site

Moderna (MRNA) PT Lowered to $325 at Jefferies

November 5, 2021 8:24 AM EDT Send to a Friend
Jefferies analyst Michael Yee lowered the price target on Moderna (NASDAQ: MRNA) to $325.00 (from $375.00) while maintaining a Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login